Concepedia

Author

Thomas Köhnke

Ludwig-Maximilians-Universität MünchenORCID

Also Known As

Köhnke, Thomas, T Köhnke, T. Kohnke, T. Köhnke, Thomas Koehnke, Thomas Kohnke, Thomas Köhnke, Thomas Köhnke

197

Publications

2.4K

Citations

23

H-Index

39

Concepts

All Affiliations

Ludwig-Maximilians-Universität MünchenStanford UniversityLMU KlinikumHelmholtz Zentrum MünchenGerman Cancer Research Center
TK

About

Thomas Köhnke is an author at Ludwig-Maximilians-Universität München specializing in medicine, immunology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

744

2

Cell Biology

3

3

299

3

Health Sciences

2

2

227

4

Cellular Therapies

1

1

33

5

Gastroenterology

1

1

27

Thomas Köhnke

×

25

Publications

2.1K

Citations

19

H-Index

YearCitations

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML

Sascha Haubner, Fabiana Perna, Thomas Köhnke,

Leukemia

2018

311

Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism

Christina Krupka, Peter Kufer, Roman Kischel,

Leukemia

2015

239

Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia

Haijiao Zhang, Yusuke Nakauchi, Thomas Köhnke,

Nature Cancer

2020

200

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330

Christina Krupka, Peter Kufer, Roman Kischel,

Blood

2013

199

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab

Thomas Köhnke, Christina Krupka, Johanna Tischer,

Journal of Hematology & Oncology

2015

173

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia

Maja Rothenberg‐Thurley, Susanne Amler, Dennis Göerlich,

Leukemia

2018

137

Single-cell mutational profiling enhances the clinical evaluation of AML MRD

Asiri Ediriwickrema, Alexey Aleshin, Johannes G. Reiter,

Blood Advances

2020

92

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

M. Hubmann, Thomas Köhnke, Eva Hoster,

Haematologica

2014

91

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings

Johanna Tischer, Nicole Engel, Susanne Fritsch,

Annals of Hematology

2015

70

Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis

Karsten H. Weylandt, Anja Nadolny, Lena Kahlke,

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

2008

67

Page 1